Stock Events

Stock Events

Search...

MoonLake Immunotherapeutics (MLTX) Q4 2025 Earnings

5NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-1.1

-0.94

-0.78

-0.62

Details

Expected EPS

-0.878837

Actual EPS

-1.1

Surprise EPS

-0.22

Surprise Percent

+25.17%

Description

MoonLake Immunotherapeutics (MLTX) has reported earnings of -1.1 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.